Search
for
Sort by
Research 361–390 of 1000+
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- Hair disorders in patients with cancer
- Hair keratin KRT81 is expressed in normal and breast cancer cells and contributes to their invasiveness
- Ayurveda-Based Supportive Care Using Guduchi, Ashwagandha, and Curcumin for Breast Cancer Patients: A Pilot Observational Study on Quality of Life and Safety
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer
- Alopecia With Endocrine Therapies in Patients With Cancer
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Psychological burden of alopecia areata in patients with cancer: A narrative review
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma